Codexis (CDXS) Enterprise Value (2010 - 2026)
Codexis (CDXS) posted quarterly Enterprise Value of -$65.1 million for Q1 2026, down 8.9% year-over-year from -$71.5 million in Q1 2025, and up 16.71% quarter-over-quarter from -$78.2 million in Q4 2025.
Codexis (CDXS) Enterprise Value (2010 - 2026) Analysis & Trends
Codexis' Enterprise Value history runs 17 years deep, the most recent figure standing at -$65.1 million for Q1 2026.
- In Q1 2026, Enterprise Value fell 8.9% year-over-year to -$65.1 million; the TTM figure through Mar 2026 stood at -$65.1 million (down 8.9% YoY), while the FY2025 annual figure was -$78.2 million, down 6.46% from the prior year.
- Enterprise Value for Q1 2026 stood at -$65.1 million, up from -$78.2 million in the prior quarter.
- The five-year high for Enterprise Value was -$2.1 million in Q1 2022, with the low at -$114.0 million in Q4 2022.
- The 5-year median for Enterprise Value is -$66.3 million (2025), against an average of -$70.0 million.
- Peak annual rise in Enterprise Value reached 98.51% in 2022, while the deepest fall reached 5075.67% in 2022.
- Codexis' Enterprise Value stood at -$114.0 million in 2022, then surged by 42.87% to -$65.1 million in 2023, then slipped by 12.82% to -$73.5 million in 2024, then retreated by 6.46% to -$78.2 million in 2025, then gained by 16.71% to -$65.1 million in 2026.
- Business Quant data shows CDXS's Enterprise Value at -$65.1 million in Q1 2026, -$78.2 million in Q4 2025, and -$58.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.29 Bn | 131.44 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 59.49 Bn | 54.36 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 42.02 Bn | 36.92 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 30.79 Bn | 27.48 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 28.26 Bn | 9.87 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.30 Bn | 26.14 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.10 Bn | 26.26 Bn | - | 2.12 Bn |
| 10 | Codexis | 144.77 Mn | 89.86 Mn | 11.40 Mn | -54.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -54.92 Mn |
| Mar 31, 2026 | -65.14 Mn |
| Dec 31, 2025 | -78.21 Mn |
| Sep 30, 2025 | -58.75 Mn |
| Jun 30, 2025 | -66.33 Mn |
| Mar 31, 2025 | -59.82 Mn |
| Dec 31, 2024 | -73.46 Mn |
| Sep 30, 2024 | -54.38 Mn |
| Jun 30, 2024 | -56.18 Mn |
| Mar 31, 2024 | -29.08 Mn |
| Dec 31, 2023 | -65.12 Mn |
| Sep 30, 2023 | -74.58 Mn |
| Jun 30, 2023 | -92.09 Mn |
| Mar 31, 2023 | -102.83 Mn |
| Dec 31, 2022 | -113.98 Mn |
| Sep 30, 2022 | -108.69 Mn |
| Jun 30, 2022 | -90.11 Mn |
| Mar 31, 2022 | -2.09 Mn |
| Dec 31, 2021 | -116.80 Mn |
| Sep 30, 2021 | -2.10 Mn |